MAIA Biotechnology (MAIA) Cash & Equivalents (2021 - 2026)
MAIA Biotechnology's Cash & Equivalents was $27.6 million in Q2 2026, up 172.0% from $10.14 million a year earlier but down 19.8% from the prior quarter.
Powered by 
Analysis
MAIA Biotechnology (MAIA) Cash & Equivalents (2021 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at MAIA Biotechnology came in at $8.66 million, down 9.8% from FY2024.
- Cash & Equivalents shows a four-year compound annual growth rate of -4.9% (FY2021 to FY2025).
- In earlier years, Cash & Equivalents was $9.6 million in FY2024 (+34.3%), $7.15 million in FY2023 (-34.7%), $10.95 million in FY2022 (+3.6%) and $10.57 million in FY2021.
- Quarterly Cash & Equivalents has moved between $6.1 million (Q3 2023) and $34.41 million (Q1 2026) over five years.
- Compared with a year earlier, Cash & Equivalents was higher in six of the last eight quarters, with growth averaging 62.5%.
- The best year-over-year quarter for Cash & Equivalents over five years was Q1 2026 (growth of 216.8%); the worst was Q3 2023 (a decline of 56.6%).
- Per Business Quant data, MAIA's Cash & Equivalents in the three quarters before Q2 2026 was $34.41 million (Q1 2026), $8.66 million (Q4 2025) and $10.89 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 976.00 Mn |
| 10 | MAIA Biotechnology | 69.78 Mn | -11.78 Mn | - | 27.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.60 Mn |
| Mar 31, 2026 | 34.41 Mn |
| Dec 31, 2025 | 8.66 Mn |
| Sep 30, 2025 | 10.89 Mn |
| Jun 30, 2025 | 10.14 Mn |
| Mar 31, 2025 | 10.86 Mn |
| Dec 31, 2024 | 9.60 Mn |
| Sep 30, 2024 | 8.69 Mn |
| Jun 30, 2024 | 11.58 Mn |
| Mar 31, 2024 | 8.27 Mn |
| Dec 31, 2023 | 7.15 Mn |
| Sep 30, 2023 | 6.10 Mn |
| Jun 30, 2023 | 9.15 Mn |
| Mar 31, 2023 | 7.59 Mn |
| Dec 31, 2022 | 10.95 Mn |
| Sep 30, 2022 | 14.06 Mn |
| Jun 30, 2022 | 8.15 Mn |
| Mar 31, 2022 | 10.29 Mn |
| Dec 31, 2021 | 10.57 Mn |
| Sep 30, 2021 | 10.95 Mn |
API Access
MAIA Biotechnology Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MAIA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "MAIA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MAIA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();